Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ILMN [NASD]
Illumina Inc.
Index- P/E158.40 EPS (ttm)0.86 Insider Own1.30% Shs Outstand128.30M Perf Week-6.60%
Market Cap17.48B Forward P/E53.27 EPS next Y2.56 Insider Trans-4.14% Shs Float126.53M Perf Month-15.89%
Income125.30M PEG8.69 EPS next Q0.45 Inst Own- Short Float16.94% Perf Quarter12.47%
Sales1.42B P/S12.30 EPS this Y-20.40% Inst Trans3.78% Short Ratio9.05 Perf Half Y69.79%
Book/sh12.10 P/B11.26 EPS next Y24.37% ROA4.40% Target Price166.40 Perf Year136.21%
Cash/sh9.08 P/C14.99 EPS next 5Y18.23% ROE8.90% 52W Range54.84 - 183.30 Perf YTD23.18%
Dividend- P/FCF59.08 EPS past 5Y24.60% ROI3.90% 52W High-25.68% Beta0.54
Dividend %- Quick Ratio4.50 Sales past 5Y19.90% Gross Margin64.20% 52W Low148.40% ATR8.52
Employees3000 Current Ratio5.00 Sales Q/Q25.20% Oper. Margin17.90% RSI (14)39.06 Volatility7.23% 6.38%
OptionableYes Debt/Eq0.65 EPS Q/Q5.70% Profit Margin8.80% Rel Volume0.80 Prev Close131.05
ShortableYes LT Debt/Eq0.63 EarningsApr 22 AMC Payout0.00% Avg Volume2.37M Price136.22
Recom2.30 SMA20-6.36% SMA50-13.99% SMA20024.77% Volume1,902,276 Change3.95%
19-Feb-14Reiterated UBS Buy $152 → $202
29-Jan-14Reiterated Mizuho Buy $150 → $175
29-Jan-14Reiterated ISI Group Neutral $134.50 → $147
17-Jan-14Reiterated Mizuho Buy $135 → $150
14-Jan-14Reiterated Mizuho Buy $125 → $135
19-Dec-13Reiterated Mizuho Buy $100 → $125
22-Oct-13Reiterated Mizuho Buy $86 → $100
22-Oct-13Reiterated Barclays Overweight $85 → $90
24-Jul-13Reiterated Mizuho Buy $83 → $86
24-Jul-13Reiterated ISI Group Neutral $75 → $78.50
23-Jul-13Reiterated UBS Buy $67 → $90
22-Jul-13Reiterated Barclays Overweight $55 → $80
23-Apr-13Reiterated UBS Buy $61 → $67
23-Apr-13Reiterated ISI Group Neutral $60 → $61.50
23-Apr-13Reiterated Cantor Fitzgerald Hold $48 → $53
09-Apr-13Reiterated Mizuho Buy $57 → $61
29-Jan-13Reiterated Cantor Fitzgerald Hold $45 → $48
04-Jan-13Downgrade Wedbush Outperform → Neutral
26-Nov-12Downgrade Robert W. Baird Outperform → Neutral $54
24-Apr-12Reiterated Mizuho Buy $62 → $52
15-Apr-14 02:32PM  Better Buy: Illumina, Inc. Vs. Intuitive Surgical, Inc. at Motley Fool
11-Apr-14 03:30PM  [video] Buying strong, defensive companies: Pro at CNBC
10-Apr-14 03:03PM  'Very Volatile' Biotech, in Chart Form at The Wall Street Journal -6.93%
08-Apr-14 01:33PM  Analyst Bullish On Medical Research, Equipment Stocks at Investor's Business Daily
07-Apr-14 05:40PM  Cancer Analysis Tools Circumvent Biopsies at New York Times
06:30AM  Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014 Business Wire
04-Apr-14 02:43PM  Investors continue to pour out of biotech holdings at MarketWatch -6.65%
03-Apr-14 03:00PM  [video] 3 to Watch: ILMN, NFLX, VVUS at CNBC -5.19%
02-Apr-14 10:00AM  Will This Upgrade Help Illumina (ILMN) Stock Today? at TheStreet
06:30AM  Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery Business Wire
01-Apr-14 12:01PM  [video] Love the agriculture commodity story: Trader at CNBC
31-Mar-14 11:14AM  Illumina: 9 Different Insiders Have Sold Shares This Month at Seeking Alpha
28-Mar-14 06:17PM  How To Tweak Your Retirement Portfolio For 2014 Market at Investor's Business Daily
26-Mar-14 08:47AM  Beat the S&P in 2014 With 5 Stocks Everyone Else Hates at TheStreet -5.34%
25-Mar-14 08:43AM  Illumina sell-off a buying opportunity, says at UBS theflyonthewall.com
24-Mar-14 01:50PM  Coverage Initiated on Illumina Zacks
07:24AM  The Covestor Healthcare Model Catches A Cold at Seeking Alpha
21-Mar-14 03:01PM  Pacific Biosciences Looking To Carve Out Its Niche at Seeking Alpha -5.42%
18-Mar-14 12:48PM  Pursuing Core Growth and Earnings Catalysts with Behavioral Finance: A Wall Street Transcript Interview with Ryan E. Crane, CFA, the Chief Investment Officer of Stephens Investment Management Group Wall Street Transcript
17-Mar-14 02:26PM  Bryan Roberts: Healthcare venture capital's billion-dollar man at Fortune
14-Mar-14 11:58AM  New China rule prompts BGI to suspend trisomy testing, GenomeWeb says at theflyonthewall.com
11:58AM  New China rule prompts BGI to suspend trisomy testing, GenomeWeb says
10:33AM  Today's Dead Cat Bounce Stock: Illumina (ILMN) at TheStreet
10:33AM  Today's Dead Cat Bounce Stock: Illumina (ILMN)
12-Mar-14 10:46AM  Clouds gather in markets; no storm forecast yet at CNBC
10:45AM  Insider Trading Alert - ITMN, M And ILMN Traded By Insiders at TheStreet
10-Mar-14 01:04PM  3 Stocks Underperforming Today In The Drugs Industry at TheStreet
01:04PM  3 Stocks Underperforming Today In The Drugs Industry
11:34AM  Investing in Durable Secular Growth Themes: A Wall Street Transcript Interview with Gavin S. Baker, a Portfolio Manager at Fidelity Management & Research Company Wall Street Transcript
06:30AM  WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System PR Newswire
06:30AM  WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System Business Wire
06:30AM  WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
09-Mar-14 08:11AM  Investing In The Future: Illumina at Seeking Alpha
08:11AM  Investing In The Future: Illumina
06-Mar-14 07:41PM  Are all the shorts dead? at MarketWatch
06:31PM  3 Reasons to Buy 2014's Smartest Company at Motley Fool
05-Mar-14 01:08PM  Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals PR Newswire
08:42AM  Illumina price target raised to $215 from $167 at JMP Securities theflyonthewall.com
08:42AM  Illumina price target raised to $215 from $167 at JMP Securities
04-Mar-14 09:13PM  How Craig Venter Plans to Challenge Google in the Race to Enhance Human Health at Motley Fool
11:05AM  In Pursuit of Longevity, a Plan to Harness DNA Sequencing at New York Times
26-Feb-14 05:00PM  Illuminas Non-Invasive verifi┬« Prenatal Test Using cfDNA Significantly Reduces False Positive Rate of Fetal Aneuploidy Detection Compared to Current Standard Pregnancy Screening Practices Business Wire
05:00PM  Illuminas Non-Invasive verifi┬« Prenatal Test Using cfDNA Significantly Reduces False Positive Rate of Fetal Aneuploidy Detection Compared to Current Standard Pregnancy Screening Practices
05:00PM  Illumina DNA Screen for Down Syndrome Found More Accurate Optionetics
05:00PM  Illumina DNA Screen for Down Syndrome Found More Accurate at Bloomberg
05:00PM  Illumina DNA Screen for Down Syndrome Found More Accurate
25-Feb-14 12:15PM  [video] Hot health care trades at CNBC
24-Feb-14 10:14AM  Trade-Ideas: Illumina (ILMN) Is Today's Momo Momentum Stock at TheStreet
08:06AM  [video] Dow 30,000 in ten years: Baron at CNBC
06:30AM  Science for Life Laboratory Joins the Illumina Genome Network Business Wire
22-Feb-14 01:04PM  ILLUMINA INC Financials EDGAR Online Financials
21-Feb-14 05:42PM  Medical Research Providers Ride Higher With Biotechs at Investor's Business Daily
18-Feb-14 05:10PM  ILLUMINA INC Files SEC form 10-K, Annual Report EDGAR Online
06:30AM  Illumina to Webcast Live Presentations at Upcoming Investment Conferences in March Business Wire
17-Feb-14 06:01AM  Illumina and a Billionaire Want to Jump-Start Genomics Upstarts at BusinessWeek
14-Feb-14 08:30PM  Yuri Milner-Backed Company Prepares IPad-Size DNA Sequencer at Forbes
02:20PM  Illumina Expands in China Zacks
13-Feb-14 04:01PM  Illumina (ILMN) On Momo Momentum Watch Today at TheStreet
06:30AM  Novogene Acquires an Illumina HiSeq X Ten Sequencing System Business Wire
12-Feb-14 08:32AM  3 Trends That Could Define Drug Discovery in 2014 at Motley Fool
06:30AM  Illumina Launches the Illumina Accelerator Program, Worlds First Genomics Incubator Business Wire
11-Feb-14 11:15AM  Insider Trading Alert - ILMN, MMS, APU, ENR And PRXL Traded By Insiders at TheStreet
10-Feb-14 05:35PM  Gap-Ups Point To Strength Among Select Big Caps at Investor's Business Daily
11:03AM  Will Illumina's Big Move Continue in 2014? at Motley Fool
08-Feb-14 10:44AM  The Path to Reading a Newborns DNA Map at New York Times
06-Feb-14 06:31PM  Can Investors Gain from the New Age in Medical Testing? at Motley Fool
05-Feb-14 08:59AM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04-Feb-14 10:45AM  Insider Trading Alert - OLN, BKU, ILMN, MOH And QCOM Traded By Insiders at TheStreet
03-Feb-14 04:31PM  ILLUMINA INC Files SEC form 8-K, Other Events EDGAR Online
31-Jan-14 03:30PM  Will This Revolutionary Health Stock Roar in 2014? at Motley Fool
03:30PM  Will This Revolutionary Health Stock Roar in 2014?
07:14AM  I Found This Company Before Angelina Jolie Did at Seeking Alpha
07:14AM  I Found This Company Before Angelina Jolie Did
30-Jan-14 03:02PM  Let Ilumina brighten up your portfolio at MarketWatch
03:02PM  Let Ilumina brighten up your portfolio
09:30AM  Illumina Beats on Q4 Earnings, Revs (revised) Zacks
09:30AM  Illumina Beats on Q4 Earnings, Revs (revised)
29-Jan-14 12:20PM  Midday movers: Sotheby's, Google, Praxair & More at CNBC
12:20PM  Midday movers: Sotheby's, Google, Praxair & More
11:59AM  Illumina Beats on Q4 Earnings, Revises Outlook Zacks
11:59AM  Illumina Beats on Q4 Earnings, Revises Outlook
10:51AM  Illumina gets mileage out of earnings as industry declines at MarketWatch
10:51AM  Illumina gets mileage out of earnings as industry declines
05:49AM  Illumina price target raised to $175 from $150 at Mizuho theflyonthewall.com
05:49AM  Illumina price target raised to $175 from $150 at Mizuho
28-Jan-14 11:42PM  Illumina's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:42PM  Illumina's CEO Discusses Q4 2013 Results - Earnings Call Transcript
11:42PM  Illumina Inc.'s CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  Illumina, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
05:00PM  Illumina, Inc. Earnings Call scheduled for 5:00 pm ET today
04:09PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Illumina Reports Strong Finish to Fourth Quarter and Fiscal Year 2013 Business Wire
07:07AM  Q4 2013 Illumina, Inc. Earnings Release - After Market Close CCBN
27-Jan-14 06:32PM  Is Thermo Fisher Scientific Inc. Destined for Greatness? at Motley Fool
22-Jan-14 01:46PM  The $1,000 Genome Marks the Start of a New Phase in Human Evolution at Motley Fool
12:50PM  Illumina, LabCorp Ink Multi-Year Deal Zacks
09:54AM  Illumina (ILMN) Showing Signs Of Being A Momo Momentum Stock at TheStreet
08:02AM  Illumina, Jazz Among 5 Young Guns Hitting New Highs at Investor's Business Daily
21-Jan-14 01:16PM  The 3 Most Intriguing Stories From the JPMorgan Healthcare Conference at Motley Fool
11:35AM  Is the S&P Coiling for a Strong Move Up or Down? Minyanville
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRADBURY DANIELDirectorApr 15Option Exercise39.142,10082,19412,024Apr 16 08:03 PM
Naclerio NicholasSr VP, Corp Develop & GMApr 15Option Exercise43.372,00086,74025,146Apr 16 08:36 PM
BRADBURY DANIELDirectorApr 15Sale131.292,100275,7059,924Apr 16 08:03 PM
Naclerio NicholasSr VP, Corp Develop & GMApr 15Sale133.562,000267,11323,146Apr 16 08:36 PM
Stapley MarcSr VP & CFOApr 14Option Exercise36.301,42251,61923,418Apr 14 09:15 PM
Stapley MarcSr VP & CFOApr 14Sale134.801,422191,69121,996Apr 14 09:15 PM
FLATLEY JAY TChief Executive OfficerApr 10Option Exercise20.0430,000601,200411,262Apr 11 05:15 PM
FLATLEY JAY TChief Executive OfficerApr 10Sale139.9030,0004,196,864381,262Apr 11 05:15 PM
BRADBURY DANIELDirectorApr 04Option Exercise39.142,10082,19412,024Apr 07 08:28 PM
BRADBURY DANIELDirectorApr 04Sale138.442,100290,7149,924Apr 07 08:28 PM
Ronaghi MostafaSr VP & CTOApr 01Option Exercise44.3810,000443,80038,604Apr 01 08:50 PM
Bouchard MichelChief Accounting OfficerApr 01Option Exercise69.3463143,75425,680Apr 01 08:49 PM
Ronaghi MostafaSr VP & CTOApr 01Sale152.4110,0001,524,06328,604Apr 01 08:50 PM
Bouchard MichelChief Accounting OfficerApr 01Sale150.3063194,84025,049Apr 01 08:49 PM
RASTETTER WILLIAM HDirectorMar 31Sale143.5029642,4764,168Apr 01 08:49 PM
FLATLEY JAY TChief Executive OfficerMar 27Option Exercise20.0430,000601,200411,262Mar 27 08:54 PM
FLATLEY JAY TChief Executive OfficerMar 27Sale140.1130,0004,203,370381,262Mar 27 08:54 PM
BRADBURY DANIELDirectorMar 19Option Exercise39.142,10082,19412,024Mar 19 07:52 PM
BRADBURY DANIELDirectorMar 19Sale161.142,100338,3929,924Mar 19 07:52 PM
Naclerio NicholasSr VP, Corporate & Venture DevMar 17Option Exercise43.372,00086,74025,146Mar 18 08:16 PM
MOELLER GERALDDirectorMar 17Option Exercise42.8110,000428,10024,620Mar 18 08:16 PM
Naclerio NicholasSr VP, Corporate & Venture DevMar 17Sale163.652,000327,30523,146Mar 18 08:16 PM
MOELLER GERALDDirectorMar 17Sale161.9210,0001,619,16314,620Mar 18 08:16 PM
Stapley MarcSr VP & CFOMar 14Option Exercise36.301,42251,61923,418Mar 14 07:40 PM
Stapley MarcSr VP & CFOMar 14Sale163.351,422232,27821,996Mar 14 07:40 PM
FLATLEY JAY TCEOMar 13Option Exercise20.0430,000601,200411,262Mar 13 07:34 PM
FLATLEY JAY TCEOMar 13Sale165.9630,0004,978,691381,262Mar 13 07:34 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerMar 11Option Exercise28.453,00085,35031,519Mar 11 07:57 PM
WALT DAVID RDirectorMar 11Option Exercise3.2410,60034,344887,088Mar 12 05:30 PM
Bouchard MichelChief Accounting OfficerMar 11Sale167.212,168362,51125,049Mar 11 07:57 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerMar 11Sale167.163,000501,47628,519Mar 11 07:57 PM
WALT DAVID RDirectorMar 10Option Exercise3.249,40030,456885,888Mar 12 05:30 PM
WALT DAVID RDirectorMar 10Sale164.209,4001,543,473876,488Mar 12 05:30 PM
Ronaghi MostafaSr VP & CTOMar 06Option Exercise44.3810,000443,80040,593Mar 10 08:30 PM
BRADBURY DANIELDirectorMar 06Option Exercise39.142,10082,19412,024Mar 10 08:30 PM
BRADBURY DANIELDirectorMar 06Sale175.102,100367,7079,924Mar 10 08:30 PM
Ronaghi MostafaSr VP & CTOMar 06Sale179.3110,0001,793,08330,593Mar 10 08:30 PM
Bouchard MichelChief Accounting OfficerMar 03Option Exercise69.3463143,75430,211Mar 04 07:22 PM
Bouchard MichelChief Accounting OfficerMar 03Sale170.24631107,42429,580Mar 04 07:22 PM
Bouchard MichelChief Accounting OfficerFeb 28Option Exercise37.042,36387,52631,943Mar 04 07:22 PM
Bouchard MichelChief Accounting OfficerFeb 28Sale178.562,363421,93729,580Mar 04 07:22 PM
FLATLEY JAY TCEOFeb 27Option Exercise20.0430,000601,200415,105Mar 03 08:00 PM
FLATLEY JAY TCEOFeb 27Sale179.3430,0005,380,214385,105Mar 03 08:00 PM
Bouchard MichelChief Accounting OfficerFeb 25Option Exercise69.3422,7251,575,75254,085Feb 25 08:59 PM
Bouchard MichelChief Accounting OfficerFeb 25Sale176.1324,5054,316,14429,580Feb 25 08:59 PM
WHITFIELD ROY ADirectorFeb 24Option Exercise19.612,00039,22011,196Feb 24 09:15 PM
WHITFIELD ROY ADirectorFeb 24Sale175.262,000350,5209,196Feb 24 09:15 PM
Naclerio NicholasSr VP, Corporate & Venture DevFeb 18Option Exercise43.372,00086,74027,781Feb 19 07:18 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerFeb 18Option Exercise28.456,000170,70036,631Feb 19 07:18 PM
Naclerio NicholasSr VP, Corporate & Venture DevFeb 18Sale169.772,000339,53925,781Feb 19 07:18 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerFeb 18Sale169.796,0001,018,75830,631Feb 19 07:18 PM
FLATLEY JAY TCEOFeb 13Option Exercise20.0430,000601,200415,105Feb 14 07:44 PM
FLATLEY JAY TCEOFeb 13Sale160.4330,0004,812,928385,105Feb 14 07:44 PM
FLATLEY JAY TCEOFeb 07Sale152.235,000761,1346,000Feb 10 08:19 PM
RASTETTER WILLIAM HDirectorFeb 03Sale151.938,5511,299,1494,464Feb 05 08:43 PM
Bianchi Paul LSr VP, Human ResourcesFeb 03Sale151.53663100,46460,374Feb 03 07:19 PM
Stapley MarcSr VP & CFOJan 31Option Exercise36.3017,064619,42338,861Feb 03 07:18 PM
Stapley MarcSr VP & CFOJan 31Sale151.3220,0383,032,23021,797Feb 03 07:18 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerJan 28Option Exercise28.456,000170,70035,250Jan 30 07:44 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerJan 28Sale143.356,000860,11329,250Jan 30 07:44 PM
FLATLEY JAY TCEOJan 23Option Exercise13.6730,000410,100419,509Jan 24 07:17 PM
FLATLEY JAY TCEOJan 23Sale142.3030,0004,269,140399,509Jan 24 07:17 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicJan 16Option Exercise28.456,000170,70036,236Jan 21 07:38 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicJan 16Sale124.546,000747,25530,236Jan 21 07:38 PM
Naclerio NicholasSVP Corp & Venture DevelopmentJan 15Option Exercise43.372,00086,74026,559Jan 17 09:22 PM
Naclerio NicholasSVP Corp & Venture DevelopmentJan 15Sale122.272,000244,54624,559Jan 17 09:22 PM
FLATLEY JAY TCEOJan 09Option Exercise10.4930,000314,550429,509Jan 10 09:08 PM
FLATLEY JAY TCEOJan 09Sale114.7730,0003,442,973399,509Jan 10 09:08 PM
EASTHAM KARINDirectorJan 02Option Exercise39.1410,000391,40018,284Jan 06 06:19 PM
EASTHAM KARINDirectorJan 02Sale109.4910,0001,094,8888,284Jan 06 06:19 PM
FLATLEY JAY TCEODec 26Option Exercise10.4930,000314,550429,509Dec 30 07:47 PM
FLATLEY JAY TCEODec 26Sale107.8830,0003,236,310399,509Dec 30 07:47 PM
Heath GregorySr VP & General ManagerDec 17Option Exercise47.811,87589,63827,990Dec 18 04:56 PM
Heath GregorySr VP & General ManagerDec 17Sale102.681,875192,52526,740Dec 18 04:56 PM
Naclerio NicholasSr VP, Corporate & Venture DevDec 16Option Exercise43.372,00086,74026,559Dec 18 04:56 PM
Naclerio NicholasSr VP, Corporate & Venture DevDec 16Sale102.762,000205,52824,559Dec 18 04:56 PM
FLATLEY JAY TPresident & CEODec 12Option Exercise10.4930,000314,550429,509Dec 16 06:17 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicDec 12Option Exercise28.456,000170,70036,236Dec 16 06:17 PM
FLATLEY JAY TPresident & CEODec 12Sale100.4730,0003,013,955399,509Dec 16 06:17 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicDec 12Sale100.486,000602,85430,236Dec 16 06:17 PM
Bouchard MichelVP, FinanceDec 02Option Exercise37.0478829,18830,749Dec 03 05:55 PM
Bouchard MichelVP, FinanceDec 02Sale97.8778877,12229,961Dec 03 05:55 PM
FLATLEY JAY TPresident & CEONov 29Option Exercise10.4930,000314,550429,509Dec 03 05:56 PM
FLATLEY JAY TPresident & CEONov 29Sale97.7730,0002,933,249399,509Dec 03 05:56 PM
WALT DAVID RDirectorNov 27Sale99.095,000495,428901,488Dec 02 02:51 PM
WHITFIELD ROY ADirectorNov 25Option Exercise19.612,00039,22011,196Nov 27 05:03 PM
WHITFIELD ROY ADirectorNov 25Sale100.002,000200,0009,196Nov 27 05:03 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicNov 21Option Exercise28.456,000170,70036,236Nov 25 06:49 PM
HENRY CHRISTIAN OSr VP, General Manager GenomicNov 21Sale94.666,000567,98830,236Nov 25 06:49 PM
Heath GregorySr VP & General ManagerNov 18Option Exercise47.811,87589,63827,990Nov 20 05:44 PM
Heath GregorySr VP & General ManagerNov 18Sale93.531,875175,36926,740Nov 20 05:44 PM
Naclerio NicholasSr VP, Corporate & Venture DevNov 15Option Exercise43.372,00086,74026,559Nov 19 06:29 PM
Naclerio NicholasSr VP, Corporate & Venture DevNov 15Sale93.212,000186,42024,559Nov 19 06:29 PM
WALT DAVID RDirectorNov 13Sale95.485,000477,381906,488Nov 15 07:01 PM
EASTHAM KARINDirectorNov 01Option Exercise17.5810,000175,75018,284Nov 05 07:48 PM
Lewis Mark LSr VP & General ManagerNov 01Option Exercise37.045,000185,20049,837Nov 05 07:48 PM
EASTHAM KARINDirectorNov 01Sale94.9910,000949,9258,284Nov 05 07:48 PM
Lewis Mark LSr VP & General ManagerNov 01Sale94.315,000471,55744,837Nov 05 07:48 PM
Bouchard MichelVP, FinanceOct 31Option Exercise37.0478729,15030,748Nov 04 09:38 PM
Bouchard MichelVP, FinanceOct 31Sale93.1478773,30129,961Nov 04 09:38 PM